AngloGold Ashanti Australia has concluded the first phase of an exploration earn-in agreement by investing A$10m in ...
- The eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial is evaluating the efficacy and safety of a single dose of BPL-003 (mebufotenin benzoate) in patients with ...